NEW BORN SCREENING – BIO – 6

At Hypro Diagnostics, our commitment to early healthcare is exemplified through the pivotal role of Newborn Screening, specifically with the Bio-6 protocol. This screening procedure is meticulously crafted to detect and evaluate a spectrum of biological markers, offering crucial insights into the health of newborns. Bio-6, a comprehensive set of tests, scrutinizes factors such as metabolic processes, enzyme activities, and hormone levels. Through the analysis of these biological indicators, our objective at Hypro Diagnostics is to identify potential health risks or congenital conditions in newborns at their earliest stages, facilitating timely intervention and personalized care. The Newborn Screening Bio-6 not only contributes to the prompt detection of health issues but also stands as a fundamental element in preventive healthcare. This underscores our unwavering dedication to ensuring the well-being of newborns through the implementation of advanced and comprehensive screening methodologies at Hypro Diagnostics.